Therapeutic misadventure with paracetamol: fact or fiction?

American Journal of Therapeutics
L F Prescott

Abstract

As a consequence of its consistent safety profile and the low incidence of side effects, paracetamol is one of the most widely used analgesics, both in adults and children. However, paracetamol has the potential for hepatotoxicity, usually as a result of deliberate self-poisoning or, to a much lesser extent, accidental overdose. A variety of factors is thought to influence hepatotoxicity, including dose, concomitant use of microsome-inducing agents and other drugs, underlying disease, malnutrition, fasting, acute and chronic alcohol intake, ethnicity, and age. Unfortunately, none of these factors has been properly studied in humans. From a physiological standpoint, acute paracetamol hepatotoxicity at therapeutic doses is extremely unlikely despite reports of so-called therapeutic misadventure. It is clear that, in many of these cases, grossly excessive doses of paracetamol have been taken. Analyzing the various reports is difficult as the data are often incomplete. In summary, although hepatic toxicity is recognized in patients taking a major paracetamol overdose, the incidence of adverse events with its proper use is very low, particularly when considering with the enormous volume of drug use. Therapeutic misadventure is extre...Continue Reading

Citations

Apr 4, 2009·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Buket TasmaciogluAbdullah Sonsuz
Mar 10, 2010·Inflammopharmacology·Garry G GrahamAnthoulla Mohamudally
Sep 5, 2003·Journal of Clinical Epidemiology·Loren LipworthJørgen H Olsen
Jul 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ping ZhaoJohn T Slattery
Apr 10, 2002·American Journal of Therapeutics·Bernhard H Lauterburg
Jan 22, 2005·American Journal of Therapeutics·C Jane NiklesDavid Wilkinson
Mar 16, 2005·American Journal of Therapeutics·Gordon D BensonKeith G Tolman
Jul 14, 2004·Annals of the Rheumatic Diseases·C Miceli-RichardM Dougados
Jan 8, 2011·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Hideya KokubunKazuo Yago
Mar 13, 2012·American Journal of Therapeutics·Kennon HeardRichard C Dart
Jan 18, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Sinem Ezgi GulmezNicholas Moore
Mar 18, 2008·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Susan BartelsJulie Richard
Dec 18, 2008·Anaesthesia·C D Oscier, Q J W Milner
Jul 19, 2011·Current Gerontology and Geriatrics Research·Sarah J MitchellSarah N Hilmer
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·Kenneth W Renton
May 3, 2012·Pain Research and Treatment·Aldric Hama, Jacqueline Sagen
Dec 28, 2016·The Cochrane Database of Systematic Reviews·Philip J WiffenR Andrew Moore
Jun 25, 2013·The Cochrane Database of Systematic Reviews·Christopher J DerryR Andrew Moore
Jul 13, 2017·The Cochrane Database of Systematic Reviews·Philip J WiffenBee Wee
May 2, 2013·The Cochrane Database of Systematic Reviews·Sheena Derry, R Andrew Moore
Dec 1, 2010·Therapeutic Advances in Drug Safety·Sarah J Mitchell, Sarah N Hilmer
Jan 23, 2009·The Cochrane Database of Systematic Reviews·Laurence TomsHenry J McQuay
Jun 2, 2007·Alimentary Pharmacology & Therapeutics·M SabatéJ-R Laporte
Mar 1, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Garry G GrahamRichard O Day
Oct 10, 2008·The Cochrane Database of Systematic Reviews·Laurence TomsR Andrew Moore
Oct 13, 2011·British Journal of Clinical Pharmacology·Daniel B HawcuttMunir Pirmohamed
Dec 2, 2019·The Medical Journal of Australia·Angela L ChiewNicholas A Buckley
Jun 17, 2016·The Cochrane Database of Systematic Reviews·Guy StephensR Andrew Moore
Mar 17, 2010·Journal of Perioperative Practice·Claire Frampton, Jane Quinlan
Jan 27, 2009·The Mount Sinai Journal of Medicine, New York·Hui-Hui TanPaul Martin
Mar 7, 2020·Clinical Liver Disease·James H Lewis, Leonard B Seeff
Apr 10, 2002·American Journal of Therapeutics·Alison Jones
Feb 2, 2021·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Jean Franco Quispe-CañariChristian R Mejia
Apr 5, 2007·The Medical Journal of Australia·John S LubelPaul J Gow
Jun 28, 2006·Gastroentérologie Clinique Et Biologique·Alexandre LouvetPhilippe Mathurin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.